Latest Breaking News On - Steven sangha - Page 1 : comparemela.com

BetterLife Announces Closing of $1 168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001

VANCOUVER, British Columbia, April 03, 2024 BetterLife Pharma Inc. , an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental.

United kingdomBritish columbiaAhmad doroudianDavid mellesSteven sanghaBetterlife pharmaBetterlife pharma incQlife pharmaConvertible debenturesChief executive officerMultilateral instrumentInvestor relations

BetterLife Announces Closing of $1 168 Million Convertible Debentures to Further Advance

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU ), an emerging biotech company focused

United kingdomBritish columbiaBetterlife pharmaSteven sanghaDavid mellesAhmad doroudianBetterlife pharma incQlife pharmaConvertible debenturesChief executive officerMultilateral instrumentInvestor relations

BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada

BetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canada
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

British columbiaNiagara fallsCity ofUnited kingdomSteven sanghaAhmad doroudianDavid mellesVern lewisBetterlife pharmaUniversity of british columbiaBetterlife pharma incUniversity of western ontarioCarleton university department of neuroscience ottawaFund family officeArgel aguilar vallesCarleton university